1 results match your criteria: "Switzerland and Oslo University Hospital[Affiliation]"
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care Res (Hoboken)
January 2024
University Hospital Zurich, University of Zurich, Zurich, Switzerland and Oslo University Hospital, Oslo, Norway.
Article Synopsis
- The study investigated the outcomes of patients with systemic sclerosis (SSc) who contracted COVID-19 across different waves of the pandemic, highlighting a lack of data for this specific group.
- A total of 333 SSc patients were analyzed, revealing a reduction in severe outcomes, hospitalizations, and deaths from wave 1 to waves 2 and 3.
- The findings suggest that younger demographics, lower use of high-dose corticosteroids, and possibly improved healthcare responses contributed to better outcomes for SSc patients as the pandemic progressed.